181 related articles for article (PubMed ID: 31994895)
21. Increase of apoptosis in a murine model for severe pneumococcal pneumonia during influenza A virus infection.
Kosai K; Seki M; Tanaka A; Morinaga Y; Imamura Y; Izumikawa K; Kakeya H; Yamamoto Y; Yanagihara K; Tomono K; Kohno S
Jpn J Infect Dis; 2011; 64(6):451-7. PubMed ID: 22116322
[TBL] [Abstract][Full Text] [Related]
22. The annexin A1/FPR2 signaling axis expands alveolar macrophages, limits viral replication, and attenuates pathogenesis in the murine influenza A virus infection model.
Schloer S; Hübel N; Masemann D; Pajonczyk D; Brunotte L; Ehrhardt C; Brandenburg LO; Ludwig S; Gerke V; Rescher U
FASEB J; 2019 Nov; 33(11):12188-12199. PubMed ID: 31398292
[TBL] [Abstract][Full Text] [Related]
23. Aspirin-triggered resolvin D1 reduces pneumococcal lung infection and inflammation in a viral and bacterial coinfection pneumonia model.
Wang H; Anthony D; Yatmaz S; Wijburg O; Satzke C; Levy B; Vlahos R; Bozinovski S
Clin Sci (Lond); 2017 Sep; 131(18):2347-2362. PubMed ID: 28779028
[TBL] [Abstract][Full Text] [Related]
24. Cysteinyl Maresins Reprogram Macrophages to Protect Mice from Streptococcus pneumoniae after Influenza A Virus Infection.
P Tavares L; Brüggemann TR; M Rezende R; G Machado M; Cagnina RE; Shay AE; C Garcia C; Nijmeh J; M Teixeira M; Levy BD
mBio; 2022 Aug; 13(4):e0126722. PubMed ID: 35913160
[TBL] [Abstract][Full Text] [Related]
25. Toll-like receptor 2 does not contribute to host response during postinfluenza pneumococcal pneumonia.
Dessing MC; van der Sluijs KF; Florquin S; Akira S; van der Poll T
Am J Respir Cell Mol Biol; 2007 May; 36(5):609-14. PubMed ID: 17170383
[TBL] [Abstract][Full Text] [Related]
26. Limited anti-inflammatory role for interleukin-1 receptor like 1 (ST2) in the host response to murine postinfluenza pneumococcal pneumonia.
Blok DC; van der Sluijs KF; Florquin S; de Boer OJ; van 't Veer C; de Vos AF; van der Poll T
PLoS One; 2013; 8(3):e58191. PubMed ID: 23483993
[TBL] [Abstract][Full Text] [Related]
27. Role of granulocyte macrophage colony-stimulating factor during gram-negative lung infection with Pseudomonas aeruginosa.
Ballinger MN; Paine R; Serezani CH; Aronoff DM; Choi ES; Standiford TJ; Toews GB; Moore BB
Am J Respir Cell Mol Biol; 2006 Jun; 34(6):766-74. PubMed ID: 16474098
[TBL] [Abstract][Full Text] [Related]
28. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection.
van der Sluijs KF; van Elden LJ; Nijhuis M; Schuurman R; Pater JM; Florquin S; Goldman M; Jansen HM; Lutter R; van der Poll T
J Immunol; 2004 Jun; 172(12):7603-9. PubMed ID: 15187140
[TBL] [Abstract][Full Text] [Related]
29. Influenza virus infection causes neutrophil dysfunction through reduced G-CSF production and an increased risk of secondary bacteria infection in the lung.
Ishikawa H; Fukui T; Ino S; Sasaki H; Awano N; Kohda C; Tanaka K
Virology; 2016 Dec; 499():23-29. PubMed ID: 27632562
[TBL] [Abstract][Full Text] [Related]
30. Halothane modulates the type i interferon response to influenza and minimizes the risk of secondary bacterial pneumonia through maintenance of neutrophil recruitment in an animal model.
MacDonald BA; Chakravarthy KV; Davidson BA; Mullan BA; Alluri R; Hakansson AP; Knight PR
Anesthesiology; 2015 Sep; 123(3):590-602. PubMed ID: 26120770
[TBL] [Abstract][Full Text] [Related]
31. Influenza a virus and
Xiang L; Zhou TJ; Zhou LL; Luo J; Qin Z; You JZ; Jian J; Zhao ZY; Zhou YS; Ye YC; Wang HR; Wang BN; Li MY
J Biol Regul Homeost Agents; 2019; 33(5):1437-1449. PubMed ID: 31637902
[TBL] [Abstract][Full Text] [Related]
32. Age predicts cytokine kinetics and innate immune cell activation following intranasal delivery of IFNγ and GM-CSF in a mouse model of RSV infection.
Eichinger KM; Resetar E; Orend J; Anderson K; Empey KM
Cytokine; 2017 Sep; 97():25-37. PubMed ID: 28558308
[TBL] [Abstract][Full Text] [Related]
33. Influenza A virus facilitates Streptococcus pneumoniae transmission and disease.
Diavatopoulos DA; Short KR; Price JT; Wilksch JJ; Brown LE; Briles DE; Strugnell RA; Wijburg OL
FASEB J; 2010 Jun; 24(6):1789-98. PubMed ID: 20097876
[TBL] [Abstract][Full Text] [Related]
34. A Perfect Storm: Increased Colonization and Failure of Vaccination Leads to Severe Secondary Bacterial Infection in Influenza Virus-Infected Obese Mice.
Karlsson EA; Meliopoulos VA; van de Velde NC; van de Velde LA; Mann B; Gao G; Rosch J; Tuomanen E; McCullers J; Vogel P; Schultz-Cherry S
mBio; 2017 Sep; 8(5):. PubMed ID: 28928207
[TBL] [Abstract][Full Text] [Related]
35. Filamentous influenza A virus infection predisposes mice to fatal septicemia following superinfection with Streptococcus pneumoniae serotype 3.
Speshock JL; Doyon-Reale N; Rabah R; Neely MN; Roberts PC
Infect Immun; 2007 Jun; 75(6):3102-11. PubMed ID: 17403870
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic effects of garenoxacin in murine experimental secondary pneumonia by Streptococcus pneumoniae after influenza virus infection.
Fukuda Y; Furuya Y; Nozaki Y; Takahata M; Nomura N; Mitsuyama J
Diagn Microbiol Infect Dis; 2014 Feb; 78(2):168-71. PubMed ID: 24321356
[TBL] [Abstract][Full Text] [Related]
37. Polygalasaponin F treats mice with pneumonia induced by influenza virus.
Ye Y; Wang H; Liu J; Zhao F; Xu P
Inflammopharmacology; 2020 Feb; 28(1):299-310. PubMed ID: 31446589
[TBL] [Abstract][Full Text] [Related]
38. The effect of intravenous peramivir, compared with oral oseltamivir, on the outcome of post-influenza pneumococcal pneumonia in mice.
Tanaka A; Nakamura S; Seki M; Iwanaga N; Kajihara T; Kitano M; Homma T; Kurihara S; Imamura Y; Miyazaki T; Izumikawa K; Kakeya H; Yanagihara K; Kohno S
Antivir Ther; 2015; 20(1):11-9. PubMed ID: 24517996
[TBL] [Abstract][Full Text] [Related]
39. GM-CSF transgene expression in the airway allows aerosolized ovalbumin to induce allergic sensitization in mice.
Stämpfli MR; Wiley RE; Neigh GS; Gajewska BU; Lei XF; Snider DP; Xing Z; Jordana M
J Clin Invest; 1998 Nov; 102(9):1704-14. PubMed ID: 9802884
[TBL] [Abstract][Full Text] [Related]
40. A Kampo (traditional Japanese herbal) medicine, Hochuekkito, pretreatment in mice prevented influenza virus replication accompanied with GM-CSF expression and increase in several defensin mRNA levels.
Dan K; Akiyoshi H; Munakata K; Hasegawa H; Watanabe K
Pharmacology; 2013; 91(5-6):314-21. PubMed ID: 23796966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
